Cita APA (7a ed.)

Andres-Ejarque, R., Ale, H. B., Grys, K., Tosi, I., Solanky, S., Ainali, C., . . . Consortium, t. P. (2021). Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis. Nature Portfolio.

Cita Chicago Style (17a ed.)

Andres-Ejarque, Rosa, et al. Enhanced NF-κB Signaling in Type-2 Dendritic Cells at Baseline Predicts Non-response to Adalimumab in Psoriasis. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Andres-Ejarque, Rosa, et al. Enhanced NF-κB Signaling in Type-2 Dendritic Cells at Baseline Predicts Non-response to Adalimumab in Psoriasis. Nature Portfolio, 2021.